Filter by: patients
Home > Community Treatment Reports and Side Effects > Interferon beta-1a IM Injection Treatment Report
What is Interferon beta-1a IM Injection?

Interferon beta-1a is a drug in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells while Interferon beta-1b is produced in modified E. coli. Interferons have been shown to have about a 30–35% reduction in the rate of MS relapses, and to slow the progression of disability in MS patients.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 2458 800 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 54 11 Efficacy_major Efficacy_moderate Efficacy_none Efficacy_cant_tell
General health 24 10 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Don't know 14 4 Efficacy_slight Efficacy_none Efficacy_cant_tell
Fatigue 14 2 Efficacy_major Efficacy_slight
Improve mobility 12 5 Efficacy_slight Efficacy_none Efficacy_cant_tell

See all 1522 patients currently taking Interferon beta-1a IM Injection

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 216
Moderate
 289
Mild
 253
None
 68

Commonly reported side effects, conditions, and hospitalizations associated with Interferon beta-1a IM Injection

Flu like symptoms 326
Generalized muscle aches 222
Chills/fever 213
Body Aches 177
Headaches 119
Joint pain 88
See all 198 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Interferon beta-1a IM Injection. See all 87 dosages ►

  weekly 1 mg weekly 1 mcg weekly 30 mcg/0.5 mL every other week 22 mcg/0.5 mL weekly 30 mg weekly 30 mcg weekly 30 mcg/0.5 mL weekly 30 mcg/0.5 mL daily 30 mcg daily
  148 Number of Patients: 148 13 Number of Patients: 13 20 Number of Patients: 20 16 Number of Patients: 16 11 Number of Patients: 11 22 Number of Patients: 22 417 Number of Patients: 417 614 Number of Patients: 614 74 Number of Patients: 74 27 Number of Patients: 27  

Reported Stop Reasons

Why Patients Stopped Taking Interferon beta-1a IM Injection (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 656   Side effects too severe: 43%
Did not seem to work 510   Did not seem to work: 34%
Doctor's advice 453   Doctor's advice: 30%
Other 246   Other: 16%
Expense 70   Expense: 5%
Personal research 51   Personal research: 3%
Course of treatment ended 29   Course of treatment ended: 2%
Change in health plan coverage 29   Change in health plan coverage: 2%
Not indicated 25   Not indicated: 2%

See all 1437 patients who’ve stopped taking Interferon beta-1a IM Injection

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Interferon beta-1a IM Injection

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Interferon beta-1a IM Injection

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Interferon beta-1a IM Injection

Always
 677 82%
Usually
 113 14%
Sometimes
 10 1%
Never
 26 3%

Burden

Difficulty being on treatment

Burden of Interferon beta-1a IM Injection

Very
 134 16%
Somewhat
 251 30%
A little
 261 32%
Not at all
 180 22%

Cost

Paid out of pocket

Cost of Interferon beta-1a IM Injection

$200+
 66 11%
$100-199
 48 8%
$50-99
 72 12%
$25-49
 134 22%
< $25
 281 46%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 24, 2012.